Stay updated on SAGE-547 in Severe Postpartum Depression Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 in Severe Postpartum Depression Clinical Trial page.

Latest updates to the SAGE-547 in Severe Postpartum Depression Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page shows a recent update to Study Record Dates (Last Update Posted 2025-10-14) with no changes to core study content such as title, sponsor, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedCore brand/name update from Sage Therapeutics to Supernus Pharmaceuticals, with new date references and an updated timestamp label.SummaryDifference1%

- Check39 days agoChange DetectedMajor update to operational notice and version number: moving from v3.1.0 to v3.2.0 with a government-operating-status disclaimer.SummaryDifference2%

- Check46 days agoChange DetectedMajor change: page now shows Revision: v3.1.0 and removes several drug-safety topics; indicates a content reorganization with version update rather than additions of new substantive information.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to SAGE-547 in Severe Postpartum Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 in Severe Postpartum Depression Clinical Trial page.